PBMWW Psyence Biomedical Ltd. - Warrant

NAS · US · Healthcare · psyencebiomed.com

0.0296USD+28.14%Mkt Cap: —P/E: —7d ago

Psyence Biomedical Ltd., an integrated biopharmaceutical company, focuses on the development of botanical psilocybin-based psychedelic medicines. Its lead product candidate is NPX-5, a botanical drug candidate that is in…

Key Statistics

Company

Market Cap—

Enterprise Value—

Revenue (TTM)—

Gross Profit—

Net Income (TTM)-6.94M USD

Revenue/Share—

Last Price0.0296 USD

Fiscal Year End—

MR Quarter—

Employees12

CountryUS

SectorHealthcare

Industry—

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)—

PEG—

EV/EBITDA—

EV/Revenue—

P/S—

P/B0.00

EPS (TTM)—

EPS (Forward)—

52W Range

0.018967% of range0.0349

52W High0.0349 USD

52W Low0.0189 USD

Profitability

Gross Margin0.00%

Oper. Margin0.00%

EBITDA Margin0.00%

Profit Margin0.00%

ROE-40.94%

ROA-39.48%

Growth

Revenue Growth—

Earnings Growth—

Cash Flow & Leverage

Operating CF-8.14M USD

CapEx (TTM)500.23K USD

FCF Margin—

FCF Yield—

Net Debt-7.44M USD

Net Debt/EBITDA1.19

Balance Sheet

Debt/Equity—

Current Ratio14.62

Quick Ratio12.12

Book Value/Sh7.39 USD

Cash/Share1.95 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.00 USD

Div. Yield—

5Y Avg Yield—

Payout Ratio—

Ex-Div Date—

Pay Date—

Analyst Consensus

Rating—

Target (Mean)—

Target Range—

# Analysts—

Ownership

Shares Out.—

Float2.61M

Insiders—

Institutions—

Technical

SMA 50—

SMA 200—

Beta1.69

S&P 52W Chg15.78%

Avg Vol (30d)39.57K

Avg Vol (10d)—

Technical Indicators

RSI (14)—

MACD—

MACD Signal—

MACD Hist.—

BB Upper—

BB Middle—

BB Lower—

BB Width—

ATR (14)—

Vol Ratio (20d)—

PBMWW Psyence Biomedical Ltd. - Warrant

Industry Peers

Key Statistics